SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Pulmonology Consultation — Leonard Nimoy — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.
| Patient | Leonard Nimoy |
|---|
| Date of birth | 1931-03-26 |
|---|
| Identifiers | MRN HR-ML017-SYN-TD; SSN (made up) 000-17-6604 |
|---|
| Document date | 2014-03-10 |
|---|
| Author | Owen Rasmussen, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Referral
COPD in an 82-year-old former smoker, now confirmed on spirometry as GOLD 3. Please confirm the grade and group, review the inhaler choice and the place of an inhaled corticosteroid, assess his oxygen needs, and advise on pulmonary rehabilitation and lung cancer screening. [S]
Urgency: Routine, within four weeks. [S]
Questions for the consultant:
- Do you agree with GOLD 3, group B, and is anything other than COPD contributing to his breathlessness?
- Is a long-acting bronchodilator pair in a soft mist inhaler the right start, and is there any place for an inhaled corticosteroid?
- Does he need oxygen at rest or on exertion?
- Does the alpha-1 antitrypsin level need further testing, and does he need chest CT for emphysema, lung volume reduction, or lung cancer screening?
- Should he start pulmonary rehabilitation now, and what should we watch for?
History of Present Illness
Mr. Nimoy is seen at the request of Dr. Benedetti four weeks after starting tiotropium-olodaterol. He smoked heavily for many years, quit about 30 years ago through a cessation program, and has been limited by breathlessness for some time. He now stops after about 100 meters on level ground. His mornings are a little easier on the new inhaler, and his albuterol use has fallen to about four times a week. He has little cough, a small amount of clear morning sputum, and no wheeze at rest, chest pain, orthopnea, ankle swelling, snoring, or reflux. He has had no exacerbation in the past year. He is keen to keep active and to warn others about smoking. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- Leonard Nimoy was born in Boston on March 26, 1931. [D]
- He played Mr. Spock in the Star Trek television series from 1966 to 1969, later acted in and directed Star Trek films, and directed other films, including the comedy Three Men and a Baby. [D]
- In a Twitter post at the end of January 2014 he announced that he had chronic obstructive pulmonary disease: "I quit smoking 30 yrs ago. Not soon enough. I have COPD. Grandpa says, quit now!! LLAP". [D]
- In early February 2014 he posted "I'm doing OK. Just can't walk distances," and ABC News reported that he had been seen at an airport in a wheelchair. [D]
- In February 2014 he urged smokers to quit: "Smokers, please understand. If you quit after you're diagnosed with lung damage it's too late." [D]
3 later historical claims are omitted because they describe events after the index age. See the teaching note.
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Albuterol 90 mcg/actuation inhaler, two inhalations as needed for breathlessness (prescribed by his previous clinician; used once or twice most days before intake) | Two inhalations every 4 hours as needed, with a spacer | Respiratory tract route | 2013-09-15 | active | S |
| Tiotropium-olodaterol 2.5/2.5 mcg soft mist inhaler, two inhalations once daily | Two inhalations once each morning | Respiratory tract route | 2014-02-10 | active | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Chronic obstructive pulmonary disease, GOLD 3 (severe airflow limitation), group B, confirmed on spirometry; synthetic modern classification linked to his publicly disclosed COPD | active | confirmed |
J44.9 | S — Synthetic modern spirometric classification; the COPD diagnosis itself is D from his own public disclosure. |
| Former smoker, quit about 30 years ago through a cessation program | active | confirmed |
Z87.891 | S — Synthetic modern entry linked to his public account of quitting smoking. |
Physical Exam
Vital signs recorded on 2014-03-10; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|
| General | Tall man, comfortable at rest, speaking in full sentences |
| Chest | Hyperinflated; reduced breath sounds throughout with prolonged expiration; no wheeze or crackles |
| Cardiovascular | Regular rhythm; no murmur; no raised jugular venous pressure or edema |
| Extremities | No clubbing or cyanosis |
| Inhaler technique | Correct with the soft mist inhaler |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 2014-03-10 | Six minute walk test | 270 | m | Predicted about 480 m for his age, sex, height, and weight; lower limit about 380 m | Low | S |
Assessment
- COPD, GOLD 3, group B (J44.9). Confirmed: post-bronchodilator FEV1/FVC 0.43 with FEV1 46 percent predicted is GOLD grade 3. CAT 19 today (22 at intake), mMRC 3, and no exacerbation in 12 months place him in group B. Normal hemoglobin, a normal ECG, and no signs of heart failure make another main cause of his breathlessness unlikely. [S]
- Oxygen assessment. Resting saturation 93 percent. On the 6-minute walk he covered 270 m with a lowest saturation of 89 percent. He meets no criterion for long-term oxygen, and the evidence does not support oxygen for moderate exertional desaturation; an arterial blood gas is not needed while resting saturation stays above 92 percent. [S]
- Alpha-1 antitrypsin and imaging. 138 mg/dL is normal, which excludes severe deficiency; no phenotyping is needed. He is not eligible for lung cancer screening, because he quit more than 15 years ago. Chest CT is not needed now: there is no suspected complication, and lung volume reduction would only be considered if he stayed severely limited after optimal treatment and rehabilitation. [S]
Data reviewed: Intake spirometry before and after bronchodilator, the blood eosinophil count, the alpha-1 antitrypsin level, hemoglobin, creatinine, the intake ECG, the CAT and mMRC scores, and today's 6-minute walk test with continuous oximetry. [S]
Plan of Treatment
- Continue tiotropium-olodaterol two inhalations each morning, with albuterol as needed; the soft mist inhaler suits him because it needs no strong inspiratory effort. [S]
- No inhaled corticosteroid: he has had no exacerbation and his eosinophils are below 300 per microliter. Reconsider after two moderate exacerbations or one hospital stay in a year if eosinophils are 100 or more. [S]
- Pulmonary rehabilitation now, with a 6-minute walk at entry (done today) and at exit. [S]
- No oxygen; check saturation at every visit and reassess if resting saturation falls to 92 percent or less. [S]
- No further alpha-1 antitrypsin testing and no chest CT at present. [S]
- PCV20 now, RSV vaccine before the next respiratory virus season, and yearly high-dose influenza and COVID-19 vaccines. [S]
- Written action plan for flare-ups; spirometry yearly. [S]
- Discussed with Dr. Benedetti the same day; the patient agrees with the plan. [S]
- Follow-up: Primary care will continue monitoring on the CMID schedule. Pulmonology will see him again after any hospital stay for an exacerbation, two or more moderate exacerbations in a year, a fall in resting saturation to 92 percent or less, or loss of the benefit from rehabilitation. [S]